Ad-hoc | 17 December 2010 11:33
WILEX AG / Key word(s): Agreement
17.12.2010 11:33
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
WILEX AG secures further financing with shareholder loans
Munich, Germany, 17 December 2010. WILEX AG (ISIN DE0006614720 / WL6 /
Frankfurt Stock Exchange) today announced that it has signed a subordinated
loan agreement for a total amount of up to EUR 10 million, payable in two
instalments, with its two main shareholders dievini Hopp BioTech holding
GmbH & Co. KG, Walldorf, Germany (dievini) and UCB Pharma S.A., Brussels,
Belgium (UCB). dievini grants an amount of EUR 7.5 million and UCB EUR 2.5
million. Both lenders receive interest of 6% p.a.
The loan is without an expiry date and is unsecured. The lenders are
entitled to terminate their respective loan agreement upon certain
conditions. In this event, the loan becomes due for repayment within one
month. Instead of requesting repayment of the loan, the lenders are
entitled to repayment by way of a contribution in kind within a capital
increase with shareholders subscription rights. Alternatively repayment can
be made in return for shares by way of a convertible bond programme yet to
be agreed upon. Prerequisite for these repayment options are both the
resolution and execution of a capital increase with shareholders
subscription rights or of a convertible bond programme as well as an
auditor's certificate of impairment of the respective lender's claim for
repayment of the loan.
Contact
Katja Arnold (CIRO)
Corporate Communications
WILEX AG
Grillparzerstr. 10
81675 München, Germany
Phone: +49 (0)89-41 31 38-126
Fax: +49 (0)89-41 31 38-99
Email: investors@wilex.com
This communication contains certain forward-looking statements relating to
the Company's business, which can be identified by the use of
forward-looking terminology such as 'estimates', 'believes', 'expects',
'may', 'will' 'should' 'future', 'potential' or similar expressions or by a
general discussion of the Company's strategy, plans or intentions. Such
forward-looking statements involve known and unknown risks, uncertainties
and other factors, which may cause our actual results of operations,
financial position, earnings, achievements, or industry results, to be
materially different from any future results, earnings or achievements
expressed or implied by such forward-looking statements. Given these
uncertainties, prospective investors and partners are cautioned not to
place undue reliance on such forward-looking statements. We disclaim any
obligation to update any such forward-looking statements to reflect future
events or developments.
17.12.2010 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
Phone: +49 (0)89 41 31 38 - 0
Fax: +49 (0)89 41 31 38 - 99
E-mail: info@wilex.com
Internet: www.wilex.com
ISIN: DE0006614720
WKN: 661472
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------